SYNCOMF NSE filing

Syncom Formulations Appoints New Cost and Internal Auditors for FY27

The RealCase readLow impact Neutral

Syncom Formulations appointed M/s M. Goyal & Co. as Cost Auditors and M/s Bansal & Agrawal as Internal Auditors for FY27. The appointments were approved by the Board on August 11, 2026, and are effective from August 12, 2026.

Why it matters

The appointment of auditors is a standard regulatory requirement and a routine operational matter for the company. It does not involve any significant financial implications or strategic shifts.

The market read

The announcement pertains to routine corporate actions like auditor appointments and does not contain any information that would significantly impact the company's stock price or financial performance in the short term.

Syncom Formulations (India) Limited announced the appointment of new auditors for the financial year 2026-27 following recommendations from its Audit Committee and approval from the Board of Directors. The Board meeting, held on 11th August, 2026, saw the approval for the appointment of M/s M. Goyal & Co. Cost Accountants (Firm Reg. No. 000051) as the Cost Auditor.

Furthermore, M/s Bansal & Agrawal, Chartered Accountants (Firm Reg. No. 010803C), have been appointed as the Internal Auditors for the same financial year. The appointments for both roles are effective from 12th August, 2026.

The company's Board meeting commenced at 4:00 p.m. (IST) and concluded at 04:45 p.m. (IST). Syncom Formulations is also in the process of filing the corporate announcement in XBRL format and will host it on its website.

Filing to action

What to do with a filing like this

Syncom Formulations (India) Limited filed this with the NSE as a statutory disclosure, categorised under auditor changes. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Syncom Formulations (India) Limited. Read the original for the full detail.

View original filing